Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Incannex Healthcare Limited (IXHL)

5.46   -0.17 (-3.02%) 08-18 07:45
Open: 5.5 Pre. Close: 5.63
High: 5.6499 Low: 5.3892
Volume: 16,204 Market Cap: 297(M)
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.65 - 5.68 5.68 - 5.7
Low: 5.32 - 5.35 5.35 - 5.38
Close: 5.41 - 5.46 5.46 - 5.5

Technical analysis

as of: 2022-08-17 4:24:29 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 6.59     One year: 7.7
Support: Support1: 4.17    Support2: 3.25
Resistance: Resistance1: 5.65    Resistance2: 6.59
Pivot: 4.42
Moving Average: MA(5): 5.1     MA(20): 4.24
MA(100): 5.87     MA(250): 0
MACD: MACD(12,26): 0.2     Signal(9): 0
Stochastic oscillator: %K(14,3): 94.1     %D(3): 92.3
RSI: RSI(14): 71.2
52-week: High: 96.06  Low: 3.25
Average Vol(K): 3-Month: 13 (K)  10-Days: 18 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ IXHL ] has closed below upper band by 13.9%. Bollinger Bands are 13.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 17 Aug 2022
Incannex Healthcare (IXHL) Appoints Robert B. Clark to its Board - StreetInsider.com

Wed, 17 Aug 2022
Proactive news headlines including American Rare Earths, Polymetals Resources, MGC ... - KULR-TV

Tue, 16 Aug 2022
Incannex Healthcare ADR (IXHL) Stock Gains 12.50% This Week: Is It a Good Pick? - InvestorsObserver

Fri, 05 Aug 2022
Date: August 05, 2022 Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K - Marketscreener.com

Tue, 02 Aug 2022
Date: August 02, 2022 Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K - Marketscreener.com

Fri, 22 Jul 2022
5 Cannabis Stocks You Don't Want to Hit 'Snooze' On - Schaeffers Research

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 0 (M)
Shares Float 51 (M)
% Held by Insiders 8.9236e+008 (%)
% Held by Institutions 0 (%)
Shares Short 37 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS 0
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 535.3
Return on Equity (ttm) -43
Qtrly Rev. Growth 720430
Gross Profit (p.s.) 0
Sales Per Share -33.14
EBITDA (p.s.) 399040
Qtrly Earnings Growth -0.1
Operating Cash Flow 0 (M)
Levered Free Cash Flow -9 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales -0.17
Price to Cash Flow 674.31

Stock Dividends

Dividend 0
Forward Dividend 44420
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.